Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

897
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
897
Allergic Reactions02:06

Allergic Reactions

33.4K
Overview
33.4K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

725
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
725
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

149
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
149
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

821
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
821
Inflammatory Response01:28

Inflammatory Response

18.4K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
18.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Presence of Dermatologists on Social Media: Perception of the Portuguese Population].

Acta medica portuguesa·2026
Same author

Eruptive lentiginosis in resolving plaque psoriasis associated with methotrexate therapy.

Dermatology online journal·2025
Same author

Penile erosions: an atypical initial manifestation of pemphigus vulgaris.

Anais brasileiros de dermatologia·2025
Same author

Multi-Organ Adverse Reaction to Two Hypomethylating Agents: A Challenge in High-Risk Myelodysplastic Syndrome Treatment.

Hematology reports·2025
Same author

Dupilumab-associated facial and neck dermatitis successfully treated with baricitinib.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2024
Same author

Extramedullary T-lymphoblastic Crisis in a Myelodysplastic/Myeloproliferative Neoplasm with a t(12;22)/<i>MN1::ETV6</i> Translocation.

Hematology reports·2023

Related Experiment Video

Updated: Mar 23, 2026

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice
08:43

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice

Published on: January 31, 2020

7.4K

Schnitzler Syndrome: A Dramatic Response to Anakinra.

Ana Isabel Gouveia1, Manuela Micaelo2, Francesca Pierdomenico3

  • 1Hospital de Santa Maria, University Clinic of Dermatology, Lisbon, Portugal. anaisabelgouveia@hotmail.com.

Dermatology and Therapy
|March 28, 2016
PubMed
Summary

Schnitzler syndrome, a rare chronic disease, can significantly impact quality of life. Anakinra, an IL-1 receptor antagonist, offers a promising treatment, rapidly and effectively managing its symptoms.

Keywords:
AnakinraSchnitzler syndromeUrticaria

More Related Videos

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.9K
Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

8.9K

Related Experiment Videos

Last Updated: Mar 23, 2026

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice
08:43

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice

Published on: January 31, 2020

7.4K
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.9K
Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

8.9K

Area of Science:

  • Rheumatology
  • Immunology
  • Dermatology

Background:

  • Schnitzler syndrome is a rare autoinflammatory disorder.
  • It is characterized by chronic, systemic manifestations.
  • Treatment options for Schnitzler syndrome are often limited and refractory to conventional therapies.

Purpose of the Study:

  • To report a case of Schnitzler syndrome treated with anakinra.
  • To evaluate the efficacy of anakinra in managing refractory Schnitzler syndrome.

Main Methods:

  • A 50-year-old female patient with a 10-year history of Schnitzler syndrome was treated.
  • The patient received anakinra, an interleukin-1 (IL-1) receptor antagonist.
  • Clinical manifestations and treatment response were monitored.

Main Results:

  • Anakinra treatment led to rapid remission of Schnitzler syndrome.
  • The patient experienced sustained improvement in disease manifestations.
  • Quality of life was significantly improved during anakinra therapy.

Conclusions:

  • Anakinra is an effective therapeutic option for Schnitzler syndrome.
  • Targeting IL-1 with anakinra provides rapid and sustained symptom control.
  • This case highlights anakinra's potential in managing refractory Schnitzler syndrome.